y 27632 has been researched along with Rheumatoid Arthritis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, KW; Kim, CD; Kwon, SM; Lee, SJ; Lee, SW; Lee, WS; Park, SY; Rhim, BY | 1 |
| Pernis, AB; Ricker, E; Rozo, C; Weng, CH; Yi, W | 1 |
| Bykerk, VP; Chinenov, Y; Goodman, SM; Gupta, S; Kirou, KA; Leuenberger, L; Maharaj, RK; Pernis, AB; Rozo, C; Salmon, JE | 1 |
| He, Y; Liang, L; Sun, L; Xu, H; Yang, X; Ye, Y; Yu, X; Zhan, Z | 1 |
| Chen, DY; Dong, XQ; Fan, JJ; Huang, HW; Liang, LQ; Xu, HS; Yang, XY; Ye, YJ; Zhan, ZP | 1 |
1 review(s) available for y 27632 and Rheumatoid Arthritis
| Article | Year |
|---|---|
Rho Kinases in Autoimmune Diseases.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; B-Lymphocytes; Cell Movement; Cell Proliferation; Cell Survival; Cytoskeleton; Gene Expression; Giant Cell Arteritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Myeloid Cells; Osteoarthritis; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Scleroderma, Systemic; T-Lymphocytes | 2016 |
4 other study(ies) available for y 27632 and Rheumatoid Arthritis
| Article | Year |
|---|---|
RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: suppression by cilostazol.
Topics: ADP Ribose Transferases; Amides; Animals; Arthritis, Rheumatoid; Botulinum Toxins; Case-Control Studies; Cilostazol; Cyclic AMP; Humans; Interleukin-23; Knee Joint; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred DBA; NF-kappa B; Nitriles; Pyridines; Reference Values; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Sulfones; Synovial Fluid; Teichoic Acids; Tetrazoles; Thionucleotides; Toll-Like Receptor 2 | 2013 |
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
Topics: Adult; Aged; Amides; Arthritis, Rheumatoid; Case-Control Studies; Cells, Cultured; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-17; Interleukins; Lupus Erythematosus, Systemic; Male; Middle Aged; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Simvastatin; T-Lymphocytes; Th17 Cells | 2017 |
Antiinflammatory effect of Rho kinase blockade via inhibition of NF-kappaB activation in rheumatoid arthritis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aged; Amides; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Enzyme Activation; Female; Humans; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Middle Aged; NF-kappa B; Pyridines; Rats; rho-Associated Kinases; Signal Transduction; Synovial Membrane; Tumor Necrosis Factor-alpha | 2008 |
[Cytokine in synovial monocytic cells from rheumatoid arthritis patients].
Topics: Amides; Arthritis, Rheumatoid; Cytokines; Enzyme Inhibitors; Female; Humans; Interleukin-10; Interleukin-6; Macrophages; Male; Monocytes; Pyridines; rho-Associated Kinases; Synovial Membrane; Tumor Necrosis Factor-alpha | 2009 |